I graduated from St Mary’s Hospital Medical School, London and went on to complete my general medical training in London followed by 7 years Oncology training at St Bartholomew’s, Mount Vernon, The Middlesex, and The Royal Free Hospitals in London.
ASCO merit award for research in radiosensitivity 1999.
Our Prostate Brachytherapy work has won prizes at the British Uro-Oncology Group 2010 and the UK and Ireland Prostate Brachytherapy Meeting 2017 and 2018.
Principle Investigator for National trials in Prostate cancer, Testicular cancer, renal cancer and genetics. Previous Collaborative research with the MRC Cell Mutation Unit in Brighton.
Recent publications below:
10 year outcomes of real time “4D” prostate brachytherapy in prostates up to 100 ml. (Euro Urol 27 March 2017).
Addition of docetaxel, zolendronic acid, or both to first line Long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive multiform, multistage, platform randomised controlled trial. (The Lancet 2016).
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor prognosis germ cell tumours (MRC23). European Urology 2015.
American Society of Clinical Oncology
American Brachytherapy Society
European Urology Association
European Society of Therapeutic Radiation Oncology
Fellow of Royal College Of Radiologists
Fellow of Royal College of Physicians
British Medical Association
I am currently the Regional Advisor for Clinical Oncology in the Oxford/Thames Valley Region for the Royal College of Radiologists. I am an Educational Supervisor for Clinical Oncology Registrars.
Previously I was Training Program Director for Clinical Oncology with the Oxford Deanery. I have been the Trust Research & Development lead. I hosted the 2011 UK and Ireland Prostate Brachytherapy Conference in Windsor.
I accept sponsorship to attend Oncological Conferences from a variety of companies. I have been paid for advisory board work and to deliver educational talks. I am an investor in the Genesis Care,Windsor, Diagnostic and Oncology Centre.